Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check28 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded the ALLIANCE Brief Report citation (Aug 2024; DOI 10.1097/QAI.0000000000003434) and removed the Erratum entry (Oct 2024; DOI 10.1097/QAI.0000000000003494); page revision updated from v3.0.1 to v3.0.2.SummaryDifference1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of new drug combinations and pharmaceutical preparations. Notably, the revision number has been updated to v3.0.0.SummaryDifference10%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.